These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 33846621)
1. A 'no-brainer' decision to become a COVID-19 vaccine-centre volunteer. Payne D Nature; 2021 Apr; 592(7854):480. PubMed ID: 33846621 [No Abstract] [Full Text] [Related]
2. Earth science a 'no-brainer' for NASA's science chief. Voosen P Science; 2017 Mar; 355(6330):1112. PubMed ID: 28302804 [No Abstract] [Full Text] [Related]
4. Measurement of the Brain Atrophy Index To Predict Mortality: a 'No-Brainer'? van den Berg JC Eur J Vasc Endovasc Surg; 2023 Mar; 65(3):346-347. PubMed ID: 36566983 [No Abstract] [Full Text] [Related]
8. Rituximab for PTLD of the CNS: is it a 'no-brainer'? Reshef R; Tsai DE Onkologie; 2008 Dec; 31(12):650-1. PubMed ID: 19060501 [No Abstract] [Full Text] [Related]
9. Social Media Engagement and Influenza Vaccination During the COVID-19 Pandemic: Cross-sectional Survey Study. Benis A; Khodos A; Ran S; Levner E; Ashkenazi S J Med Internet Res; 2021 Mar; 23(3):e25977. PubMed ID: 33651709 [TBL] [Abstract][Full Text] [Related]
10. Preparing the public for COVID-19 vaccines: How can general practitioners build vaccine confidence and optimise uptake for themselves and their patients? Danchin M; Biezen R; Manski-Nankervis JA; Kaufman J; Leask J Aust J Gen Pract; 2020 Oct; 49(10):625-629. PubMed ID: 33015676 [TBL] [Abstract][Full Text] [Related]
11. Why the "no-brainer" HPV vaccine is being ignored. Rubin R JAMA; 2015 Apr; 313(15):1502-4. PubMed ID: 25898032 [No Abstract] [Full Text] [Related]
12. Evaluation of COVID-19 Vaccine Refusal in Parents. Yigit M; Ozkaya-Parlakay A; Senel E Pediatr Infect Dis J; 2021 Apr; 40(4):e134-e136. PubMed ID: 33410650 [TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of a COVID-19 vaccine from a volunteer perspective]. Helguera G Medicina (B Aires); 2021; 81(1):125-126. PubMed ID: 33611258 [No Abstract] [Full Text] [Related]
14. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Schwarzinger M; Watson V; Arwidson P; Alla F; Luchini S Lancet Public Health; 2021 Apr; 6(4):e210-e221. PubMed ID: 33556325 [TBL] [Abstract][Full Text] [Related]
15. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
16. A Review of the Progress and Challenges of Developing a Vaccine for COVID-19. Sharma O; Sultan AA; Ding H; Triggle CR Front Immunol; 2020; 11():585354. PubMed ID: 33163000 [TBL] [Abstract][Full Text] [Related]
17. Latest updates on COVID-19 vaccines. Li Q; Lu H Biosci Trends; 2021 Jan; 14(6):463-466. PubMed ID: 33390384 [TBL] [Abstract][Full Text] [Related]
18. Individual preferences for COVID-19 vaccination in China. Leng A; Maitland E; Wang S; Nicholas S; Liu R; Wang J Vaccine; 2021 Jan; 39(2):247-254. PubMed ID: 33328140 [TBL] [Abstract][Full Text] [Related]
19. Dealing with vaccine hesitancy in Africa: the prospective COVID-19 vaccine context. Afolabi AA; Ilesanmi OS Pan Afr Med J; 2021; 38():3. PubMed ID: 33520072 [TBL] [Abstract][Full Text] [Related]
20. Frontiers in the COVID-19 vaccines development. Haq EU; Yu J; Guo J Exp Hematol Oncol; 2020; 9():24. PubMed ID: 32901214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]